Stock Price & Analysis

Analysis and Insights

Technical Analysis:

NOMD's stock price has shown resilience, with a recent price of $20.16 as of 2025-03-11. The stock is trading above its 20-day and 50-day moving averages, indicating a bullish trend. The RSI is at 66.13, suggesting the stock is not overbought. The MACD is positive, further supporting the bullish outlook.

Valuation Analysis:

NOMD's valuation metrics indicate a reasonable price relative to its earnings. The forward P/E ratio is in line with industry averages, suggesting the stock is fairly valued.

Fundamental Analysis:

NOMD reported strong Q4 results with a 4.3% year-over-year sales growth and an adjusted EPS beat. The company raised its annual EPS outlook, reflecting confidence in future performance. NOMD has a solid track record of growth and maintains strong cash reserves, indicating robust financial health.

Analyst Sentiment:

Analysts have a positive outlook on NOMD, with the stock being highlighted as a top pick. The consensus view supports further upside potential.

Conclusion:

Given the strong earnings, positive technical indicators, and solid fundamentals, NOMD stock is a good buy. The company's consistent growth and positive outlook for 2025 make it an attractive investment.

NOMD stock is predicted to reach $23 to $26 in 2025, driven by strong Q4 earnings, positive analyst upgrades, and improving margins. The stock surged after beating earnings expectations and raising its EPS outlook.

The S1 support level for NOMD Stock is $19.31 ,The R1 resistant level for NOMD Stock is $20.65.

As of the end of day on 2025-03-14, the price of NOMD Stock was $19.51.

The target price for NOMD Stock according to analyst rating is 23.80, with the highest price target at 25.00 and the lowest at 23.00. Analysts have a Strong Buy rating on NOMD Stock overall.

The market cap of NOMD is $3.0B.

Analysis and Insights

NOMD may be overvalued based on its current financials and market performance. Here's a concise analysis:

1. Revenue Growth: NOMD reported a 4.3% year-over-year increase in Q4 sales, beating expectations, driven by strong brand investments and operational efficiency.

2. Valuation Metrics:

   • The stock trades at a P/E ratio of 24.5, higher than the industry average, indicating a premium valuation.
   • EV/EBITDA of 14.1 suggests the market is pricing in high growth expectations.

3. Price Movement: NOMD rose 2.65% after earnings but remains below its 50-day moving average, signaling cautious market sentiment.

4. Future Outlook: Management expects 1-3% organic revenue growth and 2-4% adjusted EBITDA growth, with EPS projected between €1.85-1.89, reflecting confidence but not justifying the current valuation.

Conclusion

NOMD's strong financial performance is offset by high valuation metrics, suggesting it may be overvalued. Investors should weigh the stock's growth potential against its current price.

Nomad Foods Limited is a frozen food company. The Company’s portfolio of food brands within the frozen category includes Birds Eye, Findus, iglo, Belviva, Aunt Bessie’s, Goodfella’s, and others. Its products are sold primarily through grocery retailers under the Birds Eye brand in the United Kingdom and Ireland; Findus in Italy, France, Spain, Sweden, Switzerland, and Norway; Iglo in Germany and other continental markets; La Cocinera in Spain, Ledo in south-eastern Europe, and Frikom in Serbia and North Macedonia. Its product offerings include frozen fish products, such as fish fingers, coated fish, natural fish; ready to cook vegetable products, such as peas and spinach; and frozen poultry and meat products, such as nuggets, grills, and burgers. It also includes a variety of other offerings, such as soups, pizza, bakery goods and meat substitutes. The Company manufactures, sells, and distributes a range of branded frozen food products across over 13 European countries.

NOMD stock is predicted to reach $35–$40 by 2030, driven by strong brand portfolio growth and operational efficiency. Current price is $20.16, with analysts raising targets to $23–$26.

NOMD has a total of 7894 employees.